Alphabet's (GOOGL) Isomorphic raises USD 2bln for AI-designed drugs

Alphabet's Isomorphic securing $2 billion for AI-designed drugs signals a strong commitment to leveraging technology in pharmaceuticals.

Newsquawk StaffPublished On the live feed at 5 more headlines followed before this page went public
Newsquawk headlinesUTC

US President Trump says 100% we get Iran's nuclear dust

Key Context's Tae Kim says Qualcomm (QCOM) is the problem child of the current chip rally;... "I'm extremely bearish"

Alphabet's (GOOGL) Isomorphic raises USD 2bln for AI-designed drugs

Fed's Goolsbee (2027 voter) says April CPI report was worse than expected, worst part is the services inflation

Venture Global (VG) CEO says co. plans to produce 85mln metric tonnes of LNG per year by the end of 2029

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This could enhance Alphabet's value proposition and position in the healthcare sector, attracting interest from both investors and potential partners. The seriousness of their investment in AI could shift perceptions about the tech-firm's role in biotech, influencing related equities and sectors.

Related headlines

The whole workspace, free to try.

Try it free